Healthtech Startups

Clinikk is a healthcare service and product, launched in 2018, that aims to be a family's first point of contact for illnesses through affordable, accessible care. It serves individuals and families in India, combining healthcare delivery with financial protection.

4 investors

CloudCath develops a remote monitoring device for patients undergoing peritoneal dialysis at home, using optical analysis and cloud computing to track dialysate fluid safety and provide real-time alerts to clinicians and patients.

4 investors

CloudCruise provides an AI-powered platform for building and running browser automations, particularly for healthcare workflows like EHR and payer portal integrations. The platform handles script generation, execution management, error recovery, and infrastructure, with built-in HIPAA compliance and stealth features for healthcare automation.

4 investors

Clouds of Care develops EEG and electrophysiology-based digital health technology and software (including FDA-cleared/CE-marked SaMD) to provide meaningful endpoints for clinical development in CNS disorders such as epilepsy and sleep disorders. Originally spun out of academic research as Epilog, it serves clinicians, life-sciences companies, and clinical trials with brain-activity measurement, including non-invasive at-home monitoring.

4 investors

CoachCare develops technology products for healthcare providers to improve patient treatment and care delivery. The platform is designed to support front-line clinical staff in delivering better patient outcomes.

4 investors

Coagulo develops a portable point-of-care testing platform for coagulation disorder diagnosis and management using microfluidic technology and data analytics. The platform enables healthcare providers to perform comprehensive coagulation testing with drops of blood and deliver results within 10 minutes.

4 investors

Coave Therapeutics develops targeted gene therapy vectors using its proprietary ALIGATER platform to deliver therapeutic genes to specific tissues with improved safety and precision. The company focuses on treating retinal vascular diseases and other genetic conditions where traditional gene therapy delivery has been limited.

4 investors

Coherus Oncology develops and commercializes immuno-oncology therapies, including the approved LOQTORZI, to treat patients with cancer. The company focuses on expanding its pipeline of clinical-stage candidates targeting the tumor microenvironment.

4 investors

Cohesic provides decision intelligence products that integrate with healthcare IT systems to support clinical decision-making through data analysis and workflow solutions. The company serves physicians and healthcare organizations seeking to improve diagnostic accuracy and operational efficiency.

4 investors

Colorescience is a professional skincare brand that develops mineral-based sun protection (SPF), skincare, and color correction products, originally created for post-procedure skin and marketed for all ages and skin types. Its SPF products use only 100% mineral active ingredients such as zinc oxide and titanium dioxide.

4 investors

Comanche Biopharma is a biopharmaceutical company developing an investigational siRNA medicine (CBP-4888) targeting a root cause of preterm preeclampsia in pregnant women. It focuses on evidence-based therapies for life-threatening complications of pregnancy.

4 investors

Compression Works develops medical devices for emergency and critical care settings, specifically in hemorrhage control and trauma management. The company serves pre-hospital and hospital providers with innovative technologies that change standards of patient care.

4 investors

Concarlo Therapeutics is a biotech company developing cancer therapies aimed at the p27 target to treat drug-resistant cancers. It focuses on precision oncology, advancing a lead compound through preclinical development.

4 investors

Confident LIMS is a cloud-based laboratory information management system designed for analytical testing labs across industries including cannabis, food, agriculture, nutraceuticals, environmental, cosmetics, and industrial chemicals. The platform automates sample intake, testing workflows, compliance reporting, and client communication to accelerate lab turnaround time and maintain regulatory standards.

4 investors

Conflixis provides a platform for managing conflicts of interest in healthcare by integrating provider disclosures, external data, and behavioral risk signals to help organizations ensure transparency and compliance across clinician and corporate relationships.

4 investors

Congenica provides genomic variant analysis and interpretation software for clinical diagnostic laboratories. The platform enables rapid identification and prioritization of clinically relevant genetic variants from sequencing data, with applications in cancer mutation detection, germline variant analysis, and pathogen identification.

4 investors

Connie Health helps older Americans choose and navigate Medicare plans by combining technology with local licensed agents, providing unbiased plan recommendations and an ongoing local care team at no cost to the user. It operates in the US health insurance and Medicare advisory space, focused on the senior/Medicare-eligible market.

4 investors

Constant Therapy offers an app-based program of evidence-based speech, language, and cognitive therapy exercises for adults recovering from stroke, traumatic brain injury, aphasia, dementia, and other neurological conditions. It serves both patients practicing at home and speech therapists creating personalized therapy programs for clients, using an adaptive NeuroPerformance Engine to adjust exercise difficulty.

4 investors

Developing therapeutics targeting epigenetic regulators to modulate gene expression; acquired by MorphoSys in June 2021 for $1.7B.

4 investors

4 investors

Contextflow develops AI-powered diagnostic software for chest CT analysis that detects and tracks pulmonary nodules, quantifies lung tissue disease patterns, and retrieves similar clinical cases to support radiologists in evaluating suspected lung cancer, interstitial lung disease, and COPD. The ADVANCE Chest CT platform integrates into native viewers and adheres to major clinical guidelines for nodule management.

4 investors

Core Biogenesis is a French biotech that uses an oleosome fusion platform to grow active peptides and proteins (such as EGF and FGF-2) inside camelina seeds, producing formulation-ready topical delivery carriers for skin and scalp. It supplies these recombinant protein actives to the cosmetics and personal care industry, serving formulators, R&D teams, and brands.

4 investors

Corvus Pharmaceuticals is a biopharmaceutical company developing immunology-focused medicines that target cellular components of the immune system, with therapeutic focus on immune diseases and cancer.

4 investors

Counsyl was a clinical genetic-screening company offering DNA carrier screening for family planning, prenatal screening, and inherited cancer risk tests, processed in its own CLIA-certified lab. Co-founded in 2007 with Balaji Srinivasan as CTO, it screened hundreds of thousands of patients before Myriad Genetics acquired it for $375 million in 2018.

4 investors